The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients
NCT02338128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2019-07-24
Summary
The purpose of this study is to determine whether Febuxostat could protect cardiovascular function of peritoneal dialysis patients by lowering serum uric acid.
Conditions
- Disorders Associated With Peritoneal Dialysis
- Hyperuricemia
Sponsors & Collaborators
-
Shanghai 10th People's Hospital
lead OTHER
Principal Investigators
-
Ling Wang, MD, PhD · Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2018-01-31
- Completion
- 2018-01-31
Countries
- China
Study Locations
More Related Trials
-
Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients
NCT02944214 ·Status: UNKNOWN ·Phase: NA
-
Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy
NCT01984749 ·Status: UNKNOWN ·Phase: NA
-
Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout
NCT03372200 ·Status: COMPLETED ·Phase: PHASE3
-
Hyperuricemia and Diabetic Nephropathy
NCT04799925 ·Status: UNKNOWN
-
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
NCT01082640 ·Status: COMPLETED ·Phase: PHASE2
-
Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction
NCT03534037 ·Status: UNKNOWN ·Phase: PHASE4
-
the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia
NCT02279342 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Dotinurad in Hyperuricemia With Hypertension
NCT06834230 ·Status: RECRUITING ·Phase: PHASE4
-
A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis.
NCT04398251 ·Status: UNKNOWN ·Phase: PHASE4
-
Prednisone for Heart Failure Patients With Hyperuricemia
NCT02129764 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia
NCT05513976 ·Status: UNKNOWN ·Phase: PHASE2
-
Role of Uralyt-U in Patients With Hyperuricemia
NCT04352153 ·Status: UNKNOWN ·Phase: NA
-
The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF)
NCT03336203 ·Status: UNKNOWN ·Phase: PHASE4
-
Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)
NCT01101035 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Oral Febuxostat in Subjects With Gout
NCT02082769 ·Status: COMPLETED ·Phase: PHASE3
-
Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones
NCT01077284 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout
NCT04772352 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI)
NCT03767322 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Febuxostat on Blood Pressure
NCT01496469 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
NCT01472692 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Oral Febuxostat in Participants With Gout
NCT00430248 ·Status: COMPLETED ·Phase: PHASE3
-
A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients
NCT02317861 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long-Term Safety of Febuxostat in Subjects With Gout.
NCT00174941 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
NCT01078389 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
NCT02252835 ·Status: COMPLETED ·Phase: PHASE2